首页 > 资讯
May 15, 2024
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 9, 10 and 13, 2024, of EUR 24.8481 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 30,860,582 new common shares.
Distribution of the dividend with delivery of new common shares and settlement of any fractions in cash, will take place from May 16, 2024. Upon distribution, the total issued share capital will amount to EUR 188,875,310 representing 944,376,548 common shares.
In the second quarter, Philips intends to cancel 4,437,164 shares that were acquired under the now completed EUR 1.5 billion share repurchase program for capital reduction purposes, as announced on July 26, 2021. Post cancellation, the total number of issued shares will amount to 939,939,384 common shares. More information is available via this link.
For further information, please contact:
Ben Zwirs
Philips External Relations
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com
Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Forward-looking statements
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
相关推荐
- 欧洲智慧能源展:双向充电可节省数十亿美元
- Diligent宣布推出由S&P Global市场情报部门提供支持的Market Insights Reporting,为董事和高管提供无与伦比的财务和风险洞察
- 戴尔科技 x 赛轮集团:打造橡胶行业首个工业互联网平台
- 世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 全球首款!智翔金泰狂犬病被动免疫双抗斯乐韦米单抗申报上市
- 逸夫眼镜匠心之选备受认可 获得行业多项殊荣
- 健康新生态·聚势赢未来丨伽澜健康集团年度伽友峰会在京圆满举办
- 嘻哈包袱铺开启全球巡演,首战新加坡,圆满成功!
- 九三学社秦皇岛社员付占一博士后研究员入选英国皇家工艺院终身院士
- 搜索
-
- 01-16欧洲智慧能源展:双向充电可节省数十亿美元
- 01-16Diligent宣布推出由S&P Global市场情报部门提供支持的Market Insights Reporting,为董事和高管提供无与伦比的财务和风险洞察
- 01-16戴尔科技 x 赛轮集团:打造橡胶行业首个工业互联网平台
- 01-16世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 01-16世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 01-16全球首款!智翔金泰狂犬病被动免疫双抗斯乐韦米单抗申报上市
- 01-16逸夫眼镜匠心之选备受认可 获得行业多项殊荣
- 01-16健康新生态·聚势赢未来丨伽澜健康集团年度伽友峰会在京圆满举办
- 01-16嘻哈包袱铺开启全球巡演,首战新加坡,圆满成功!
- 01-16九三学社秦皇岛社员付占一博士后研究员入选英国皇家工艺院终身院士
- 标签列表